Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.
Fujirebio Holdings Inc and Sysmex Corporation today announced that they have entered into an agreement to expand their Contract Development and Manufacturing Organization
NurExone Biologic Inc has recently unveiled laboratory tests of its secondary two proprietary sequences representing a significant advancement in the treatment of spinal cord injuries
Polaris Group today announced that the first patient was successfully dosed in the Phase a clinical study for NonAlcoholic Steatohepatitis
MedAvail Holdings Inc an innovative pharmacy technology company announced today that it has entered into an agreement with New Orleansbased St Thomas Community Health
Akeso Shanghai Global RD Center was successfully held at the Zhangjiang headquarters park in Shanghai The establishment of the Akeso Global RD Center
Neumora Therapeutics Inc a clinicalstage biopharmaceutical company redefining neuroscience drug development today announced the initiation of a Phase single ascending dose multiple ascending dose study evaluating NMRA
Lexaria Bioscience Corp the Company or Lexaria a global innovator in drug delivery platforms announces positive interim results from a human pilot study currently underway
Everest Medicines a biopharmaceutical company focused on the development manufacturing and commercialization of innovative medicines and vaccines announced today that Chinas
Innovent Biologics Inc a worldclass biopharmaceutical company that develops manufactures and commercializes high quality medicines for the treatment of oncology metabolic autoimmune ophthalmology and other major diseases
WuXi Biologics a leading global Contract Research Development and Manufacturing Organization CRDMO announced today that it has accomplished endtoend DS manufacturing at pilot scale utilizing WuXiUPTM
